[1]
|
Taher, A.T., Musallam, K.M. and Cappellini, M.D. (2021) β-Thalassemias. The New England Journal of Medicine, 384, 727-743. https://doi.org/10.1056/NEJMra2021838
|
[2]
|
Taher, A.T., Weatherall, D.J. and Cappellini, M.D. (2018) Thalassaemia. The Lancet, 391, 155-167. https://doi.org/10.1016/S0140-6736(17)31822-6
|
[3]
|
Moukhadder, H.M., Halawi, R., Cappellini, M.D. and Taher, A.T. (2017) Hepatocellular Carcinoma as an Emerging Morbidity in the Thalassemia Syndromes: A Comprehensive Review. Cancer, 123, 751-758. https://doi.org/10.1002/cncr.30462
|
[4]
|
Borgna-Pignatti, C., Vergine, G., Lombardo, T., et al. (2004) Hepatocellular Carcinoma in the Thalassaemia Syndromes. British Journal of Haematology, 124, 114-117. https://doi.org/10.1046/j.1365-2141.2003.04732.x
|
[5]
|
Borgna-Pignatti, C., Garani, M.C., Forni, G.L., et al. (2014) Hepatocellular Carcinoma in Thalassaemia: An Update of the Italian Registry. British Journal of Haematology, 167, 121-126. https://doi.org/10.1111/bjh.13009
|
[6]
|
Yao, X.Y., Yu, J., Chen, S.P., et al. (2013) Prevalence and Genetic Analysis of α-Thalassemia and β-Thalassemia in Chongqing Area of China. Gene, 532, 120-124. https://doi.org/10.1016/j.gene.2013.09.031
|
[7]
|
Nemeth, E. and Ganz, T. (2023) Hepcidin and Iron in Health and Disease. Annual Review of Medicine, 74, 261-277. https://doi.org/10.1146/annurev-med-043021-032816
|
[8]
|
Camaschella, C., Nai, A. and Silvestri, L. (2020) Iron Metabolism and Iron Disorders Revisited in the Hepcidin Era. Haematologica, 105, 260-272. https://doi.org/10.3324/haematol.2019.232124
|
[9]
|
中华医学会血液学分会/中国医师协会血液科医师分会. 铁过载诊断与治疗的中国专家共识[J]. 中华血液学杂志, 2011, 32(8): 572-574.
|
[10]
|
Miya, T., Kondo, H. and Gemma, A. (2018) Serum Iron Levels Increased by Cancer Chemotherapy Correlate the Chemotherapy-Induced Nausea and Vomiting. International Journal of Clinical Oncology, 23, 1196-1200. https://doi.org/10.1007/s10147-018-1321-4
|
[11]
|
Voskaridou, E., Ladis, V., Kattamis, A., et al. (2012) A National Registry of Haemoglobinopathies in Greece: Deducted Demographics, Trends in Mortality and Affected Births. Annals of Hematology, 91, 1451-1458. https://doi.org/10.1007/s00277-012-1465-7
|
[12]
|
Sindrilaru, A., Peters, T., Wieschalka, S., et al. (2011) An Unrestrained Proinflammatory M1 Macrophage Population Induced by Iron Impairs Wound Healing in Humans and Mice. Journal of Clinical Investigation, 121, 985-997. https://doi.org/10.1172/JCI44490
|
[13]
|
Ruddell, R.G., Hoang-Le, D., Barwood, J.M., et al. (2009) Ferritin Functions as a Proinflammatory Cytokine via Iron-Independent Protein Kinase C Zeta/Nuclear Factor KappaB-Regulated Signaling in Rat Hepatic Stellate Cells. Hepatology, 49, 887-900. https://doi.org/10.1002/hep.22716
|
[14]
|
Leone, V., Ali, A., Weber, A., Tschaharganeh, D.F. and Heikenwalder, M. (2021) Liver Inflammation and Hepatobiliary Cancers. Trends Cancer, 7, 606-623. https://doi.org/10.1016/j.trecan.2021.01.012
|
[15]
|
Dixon, S.J. and Stockwell, B.R. (2014) The Role of Iron and Reactive Oxygen Species in Cell Death. Nature Chemical Biology, 10, 9-17. https://doi.org/10.1038/nchembio.1416
|
[16]
|
Poli, G. (2000) Pathogenesis of Liver Fibrosis: Role of Oxidative Stress. Molecular Aspects of Medicine, 21, 49-98. https://doi.org/10.1016/S0098-2997(00)00004-2
|
[17]
|
Turlin, B., Juguet, F., Moirand, R., et al. (1995) Increased Liver Iron Stores in Patients with Hepatocellular Carcinoma Developed on a Noncirrhotic Liver. Hepatology, 22, 446-450. https://doi.org/10.1002/hep.1840220212
|
[18]
|
Zanella, S., Garani, M.C. and Borgna-Pignatti, C. (2016) Malignancies and Thalassemia: A Review of the Literature. Annals of the New York Academy of Sciences, 1368, 140-148. https://doi.org/10.1111/nyas.13005
|
[19]
|
Pipaliya, N., Solanke, D., Parikh, P., et al. (2017) Comparison of Tissue Elastography with Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients with Thalassemia Major. Clinical Gastroenterology and Hepatology, 15, 292-298.E1. https://doi.org/10.1016/j.cgh.2016.08.046
|
[20]
|
Tsitsikas, D.A., Nzouakou, R., Ameen, V., Sirigireddy, B. and Amos, R.J. (2014) Comparison of Serial Serum Ferritin Measurements and Liver Iron Concentration Assessed by MRI in Adult Transfused Patients with Sickle Cell Disease. European Journal of Haematology, 92, 164-167. https://doi.org/10.1111/ejh.12230
|
[21]
|
张倩, 侯波, 王璐, 等. 磁共振成像技术定量检测铁过载的临床意义[J]. 中华医学杂志, 2013, 93(44): 3506-3509.
|
[22]
|
中华医学会血液学分会红细胞疾病(贫血)学组. 中国输血依赖型β地中海贫血诊断与治疗指南(2022年版) [J]. 中华血液学杂志, 2022, 43(11): 889-896.
|
[23]
|
Farmakis, D., Porter, J., Taher, A., Domenica Cappellini, M., Angastiniotis, M. and Eleftheriou, A. (2022) 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-Dependent Thalassemia. Hemasphere, 6, E732. https://doi.org/10.1097/HS9.0000000000000732
|
[24]
|
Kontoghiorghes, G.J. (2023) Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications. International Journal of Molecular Sciences, 24, Article No. 12928. https://doi.org/10.3390/ijms241612928
|
[25]
|
Parakh, N. and Chandra, J. (2022) Correlation of Transient Elastography with MRI T2* and Serum Ferritin Levels in Children with Transfusion-Dependent Thalassemia. Indian Pediatrics, 59, 929-932. https://doi.org/10.1007/s13312-022-2665-4
|
[26]
|
Bacon, B.R., Adams, P.C., Kowdley, K.V., Powell, L.W., Tavill, A.S. and American Association for the Study of Liver Diseases (2011) Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatology, 54, 328-343. https://doi.org/10.1002/hep.24330
|
[27]
|
Pepe, A., Meloni, A., Rossi, G., et al. (2013) Cardiac and Hepatic Iron and Ejection Fraction in Thalassemia Major: Multicentre Prospective Comparison of Combined Deferiprone and Deferoxamine Therapy against Deferiprone or Deferoxamine Monotherapy. Journal of Cardiovascular Magnetic Resonance, 15, 1. https://doi.org/10.1186/1532-429X-15-1
|
[28]
|
Deugnier, Y., Turlin, B., Ropert, M., et al. (2011) Improvement in Liver Pathology of Patients with β-Thalassemia Treated with Deferasirox for at Least 3 Years [Published Correction Appears in Gastroenterology. 2012 Jan; 142(1): 186]. Gastroenterology, 141, 1202-1211.E12113. https://doi.org/10.1053/j.gastro.2011.06.065
|